-
Je něco špatně v tomto záznamu ?
Diabetes, Cardiovascular Disorders and 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Body Burden in Czech Patients 50 Years After the Intoxication
T. Pelcl, J. Skrha, M. Prazny, S. Vlckova, Z. Fenclova, T. Navratil, J. Malik, P. Diblik, V. Zikan, D. Pelclova,
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články
PubMed
29569337
DOI
10.1111/bcpt.13013
Knihovny.cz E-zdroje
- MeSH
- diabetes mellitus epidemiologie etiologie MeSH
- herbicidy krev toxicita MeSH
- kardiovaskulární nemoci epidemiologie etiologie MeSH
- látky znečišťující životní prostředí krev toxicita MeSH
- lidé MeSH
- následné studie MeSH
- obsah radioaktivních látek v organizmu MeSH
- polychlorované dibenzodioxiny krev toxicita MeSH
- pracovní expozice škodlivé účinky MeSH
- prevalence MeSH
- senioři MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika epidemiologie MeSH
The correlation between 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication and the parameters of metabolic impairment was examined in the last eight male survivors of 80 workers exposed to TCDD during the production of herbicides in a chemical factory in 1965-1967. Their median TCDD blood level was 112 (46-390) pg/g lipids, and the median TCDD body deposit was 3.9 (0.8-11.7) μg. This puts these patients into the most severely intoxicated group of subjects, according to back-calculated levels of TCDD. The median TCDD blood level in eight controls was 12 pg/g (<0.10 to 22.2 pg/g). Markers of metabolic impairment - diabetes, dyslipidaemia, arterial hypertension, carotid artery plaque, skin microvascular reactivity, eye fundus hypertensive angiopathy and history of coronary heart disease - were assessed and compared to a general male population of comparable age. Measured parameters compared with a population of comparable age were as follows: prevalence of diabetes (62.5% versus 17.6%), arterial hypertension (87.5% versus 71.8%), dyslipidaemia (87.5% versus 88.8%), history of coronary heart disease (62.5% versus 26.0%) and eye fundus hypertension angiopathy (50% versus 14%). All eight patients (100% versus 43%) developed plaques in carotid arteries, six had stenosis >50% and two had a carotid intervention (stenting or endarterectomy). Total cholesterol levels decreased compared to the earlier study this patient group in 2008, most likely due to a more intensive use of lipid-lowering drugs. Several metabolic parameters were higher (diabetes as much as 3.5-fold) in the group of severely TCDD-intoxicated subjects than in a general population of comparable age. This suggests that TCDD plays a role in the development of metabolic impairment and vascular changes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19000853
- 003
- CZ-PrNML
- 005
- 20250403084241.0
- 007
- ta
- 008
- 190107s2018 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/bcpt.13013 $2 doi
- 035 __
- $a (PubMed)29569337
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Pelcl, Tomas $u 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 245 10
- $a Diabetes, Cardiovascular Disorders and 2,3,7,8-Tetrachlorodibenzo-p-Dioxin Body Burden in Czech Patients 50 Years After the Intoxication / $c T. Pelcl, J. Skrha, M. Prazny, S. Vlckova, Z. Fenclova, T. Navratil, J. Malik, P. Diblik, V. Zikan, D. Pelclova,
- 520 9_
- $a The correlation between 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication and the parameters of metabolic impairment was examined in the last eight male survivors of 80 workers exposed to TCDD during the production of herbicides in a chemical factory in 1965-1967. Their median TCDD blood level was 112 (46-390) pg/g lipids, and the median TCDD body deposit was 3.9 (0.8-11.7) μg. This puts these patients into the most severely intoxicated group of subjects, according to back-calculated levels of TCDD. The median TCDD blood level in eight controls was 12 pg/g (<0.10 to 22.2 pg/g). Markers of metabolic impairment - diabetes, dyslipidaemia, arterial hypertension, carotid artery plaque, skin microvascular reactivity, eye fundus hypertensive angiopathy and history of coronary heart disease - were assessed and compared to a general male population of comparable age. Measured parameters compared with a population of comparable age were as follows: prevalence of diabetes (62.5% versus 17.6%), arterial hypertension (87.5% versus 71.8%), dyslipidaemia (87.5% versus 88.8%), history of coronary heart disease (62.5% versus 26.0%) and eye fundus hypertension angiopathy (50% versus 14%). All eight patients (100% versus 43%) developed plaques in carotid arteries, six had stenosis >50% and two had a carotid intervention (stenting or endarterectomy). Total cholesterol levels decreased compared to the earlier study this patient group in 2008, most likely due to a more intensive use of lipid-lowering drugs. Several metabolic parameters were higher (diabetes as much as 3.5-fold) in the group of severely TCDD-intoxicated subjects than in a general population of comparable age. This suggests that TCDD plays a role in the development of metabolic impairment and vascular changes.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a obsah radioaktivních látek v organizmu $7 D001822
- 650 _2
- $a kardiovaskulární nemoci $x epidemiologie $x etiologie $7 D002318
- 650 _2
- $a Česká republika $x epidemiologie $7 D018153
- 650 _2
- $a diabetes mellitus $x epidemiologie $x etiologie $7 D003920
- 650 _2
- $a látky znečišťující životní prostředí $x krev $x toxicita $7 D004785
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a herbicidy $x krev $x toxicita $7 D006540
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a pracovní expozice $x škodlivé účinky $7 D016273
- 650 _2
- $a polychlorované dibenzodioxiny $x krev $x toxicita $7 D000072317
- 650 _2
- $a prevalence $7 D015995
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Skrha, Jan $u 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Prazny, Martin $u 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Vlckova, Stepanka $u Department of Occupational Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Fenclová, Zdeňka, $d 1958- $u Department of Occupational Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic. $7 xx0074215
- 700 1_
- $a Navratil, Tomas $u J. Heyrovsky Institute of Physical Chemistry of the CAS CR, v.v.i., Prague, Czech Republic.
- 700 1_
- $a Malik, Jan $u 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Diblik, Pavel $u Department of Ophthalmology, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Zikan, Vit $u 3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Pelclova, Daniela $u Department of Occupational Medicine, 1st Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 773 0_
- $w MED00007578 $t Basic & clinical pharmacology & toxicology $x 1742-7843 $g Roč. 123, č. 3 (2018), s. 356-359
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29569337 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190107 $b ABA008
- 991 __
- $a 20250403084236 $b ABA008
- 999 __
- $a ok $b bmc $g 1364845 $s 1038976
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 123 $c 3 $d 356-359 $e 20180507 $i 1742-7843 $m Basic & clinical pharmacology & toxicology $n Basic Clin Pharmacol Toxicol $x MED00007578
- LZP __
- $a Pubmed-20190107